Chakma Justin
ARS Pharmaceuticals, Inc. · Chief Business Officer
Chakma Justin is listed in public filings as officer: Chief Business Officer. This Chakma Justin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include ARS Pharmaceuticals, Inc. (SPRY). Investors use Chakma Justin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $360k25k shares | SellNov 27, 2024 | $14.39 | -- | |
| $593k42.2k shares | SellNov 26, 2024 | $14.05 | -- | |
| $459k32.8k shares | SellNov 25, 2024 | $14.00 | -- | |
| $615k45k shares | SellDec 2, 2024 | $13.67 | -- | |
| $593k45k shares | SellDec 3, 2024 | $13.19 | -- | |
| $712k50k shares | SellDec 6, 2024 | $14.23 | -- | |
| $628k45k shares | SellDec 4, 2024 | $13.95 | -- | |
| $702k49.6k shares | SellDec 5, 2024 | $14.13 | -- | |
| $658k50k shares | SellDec 10, 2024 | $13.15 | -- | |
| $1.4M117.3k shares | SellDec 12, 2024 | $12.27 | -- | |
| $329k27.3k shares | SellDec 13, 2024 | $12.06 | -- |